Last $52.16 USD
Change Today -0.25 / -0.48%
Volume 5.4M
TEVA On Other Exchanges
Symbol
Exchange
New York
Tel Aviv
OTC US
Mexico
Frankfurt
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - TEVA PHARMACEUTICAL-SP ADR (TEVA)

Teva Pharmaceutical Industries Limited to Report Q2, 2014 on Jul 31, 2014
CapIQ 07/31/2014 11:00 AM ET
Teva Pharmaceutical Industries Limited to Report Q1, 2014 on May 01, 2014
CapIQ 07/31/2014 11:00 AM ET
Teva Pharmaceutical Industries Limited to Report Q4, 2013 on Feb 06, 2014
CapIQ 07/31/2014 11:00 AM ET

2013 revenues at Teva Pharmaceutical Industries Limited totaled $20.3B USD, while annual earnings equaled $5.01 per share.

Quarterly Earnings & Estimates - TEVA PHARMACEUTICAL-SP ADR (TEVA)

Actuals vs. Estimates for TEVA PHARMACEUTICAL-SP ADR TEVA

Teva Pharmaceutical Industries Limited's Quarterly Earnings

Teva Pharmaceutical Industries Limited reported 2nd quarter 2014 earnings of $1.23 per share on 08/2/2014.

Annual Earnings & Estimates - TEVA PHARMACEUTICAL-SP ADR (TEVA)

Actuals vs. Estimates for TEVA PHARMACEUTICAL-SP ADR TEVA

Teva Pharmaceutical Industries Limited's Annual Earnings

Teva Pharmaceutical Industries Limited reported annual 2013 earnings of $5.01 per share on 02/8/2014.

Quarterly Revenues - TEVA PHARMACEUTICAL-SP ADR (TEVA)

Actuals vs. Estimates for TEVA PHARMACEUTICAL-SP ADR TEVA

Teva Pharmaceutical Industries Limited's Quarterly Revenues

Teva Pharmaceutical Industries Limited had 2nd quarter 2014 revenues of $5.0B USD. This missed the $5.1B USD consensus estimate of the 19 analysts following the company. This was 2.5% above the prior year's 2nd quarter results.

Annual Revenues - TEVA PHARMACEUTICAL-SP ADR (TEVA)

Actuals vs. Estimates for TEVA PHARMACEUTICAL-SP ADR TEVA

Teva Pharmaceutical Industries Limited's Annual Revenues

Teva Pharmaceutical Industries Limited had revenues for the full year 2013 of $20.3B USD. This was 0.0% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $52.16 USD -0.25

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.59 USD -0.10
Baxter International Inc $72.54 USD -0.56
Covidien PLC $90.85 USD -0.75
Eli Lilly & Co $66.53 USD -0.06
Johnson Matthey PLC 3,104 GBp -28.00
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings 17.2x
Price/Sales 2.2x
Price/Book 1.9x
Price/Cash Flow 19.2x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.